AstraZeneca advances by 4% after results and Brilinta ruling
Source: Guardian
Thursday 29th July, 2010
investors have received a double dose of good news, following strong first half results and US endorsement of its blood thinning treatment Brilinta.The company said it would double its share buyback t... ...
Read the full story at
Guardian
Email this story to a friend
Have your say on this story
